CVE-2020-27270
lowPriorität · verfolgen · 23EPSS 0.003 · 18. PerzentilEUUSEPSS · bewertet 2026-10-27
SOOIL Developments CoLtd DiabecareRS, AnyDana-i ,AnyDana-A, communication protocol of the insulin pump & AnyDana-i,AnyDana-A mobile apps doesnt use adequate measures to protect encryption keys in transit which allows unauthenticated physically proximate attacker to sniff keys via (BLE).
Behebungen
Hersteller-Fix, Mitigation oder Workaround, wie von den Quellen veröffentlicht.
Ein Hersteller-Fix ist verfügbar.
- BehobenAnyDana-Acisa_csaf_ot
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
- BehobenAnyDana-icisa_csaf_ot
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
- BehobenDana Diabecare RScisa_csaf_ot
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
cvss
Technischer Schweregrad, 0–10. Eine Zeile je Quelle.
Basiswert 0–10 · höher = schwerwiegender · Vektor überfahren zum Auflösen⚠ Quellen uneinig · low–medium · 2.9–5.7
schwächen
Die CWE-Schwächeklassen, zu denen dies gehört.
betroffene Produkte (10)
Betroffene Produkte und Versionsbereiche.
- n/a SOOIL Developments CoLtd DiabecareRS,AnyDana-i,AnyDana-A≤ Dana DiabecareRS,AnyDana-i,AnyDana-A,versions prior to 3.0enisa_euvdEU
Advisories (1)
Hersteller- und Ökosystem-Meldungen dazu.
- ICSMA-21-012-01SOOIL Dana Diabecare RS Products2021-01-12icsa · cisa_csaf_otUS
Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.
auch bekannt als (3)
Weitere Namen und Kennungen dieser Entität.
quellen
Welche Quellen diesen Datensatz belegen und wann.
Referenzen (5)
Externe Belege — Patches, Meldungen, Analysen.
- http://www.sooil.com/eng/Patchcnnvd
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01cnnvd
- https://www.auscert.org.au/bulletins/ESB-2021.0122/cnnvd
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01enisa_euvd
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01Third Party AdvisoryUS Government Resourcenvd
Angreifer nutzen Schwachstellen wie diese gegen im Internet exponierte Dienste aus. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.
Kostenloser Scan